VARANASI: According to a study undertaken by a team from Banaras Hindu University's Institute of Medical Sciences and IIT, it may be able to heal chemotherapy-induced neuropathic pain (CINP) by genetically manipulating and delivering siRNA to specific locations using nanotechnology.

Dr. Nimisha Verma of IMS-department BHU's of anesthesiology and Dr. Vinod Tiwari of IIT's department of pharmaceutical engineering conducted the study (BHU). This research was published in the January 2022 issue of a prestigious Life Science Journal.

Cancer patients, according to Dr. Tiwari, are in excruciating pain. Not just the sickness, but even the treatment for cancer can be excruciatingly painful.

Chemotherapy-induced neuropathic pain (CINP) is a type of pain that is one of the most prevalent clinical consequences linked with the use of anti-cancer drugs.

It is a serious dose-restriction and treatment-restriction side effect. The CINP occurs in about 68.1 percent of the cancer patients receiving chemotherapeutic medicines. In clinics that provide a potential insight into the management of pain, TRPV1's therapeutic value is well recognised.

Study finds, New antiviral medicine combination highly effective against COVID-19

Govt paid Rs 808 cr insurance under PMGKP to kin of 1,616 healthcare staff: Mandaviya

Eating these things in winter increases the tingling in the teeth